Cite
HARVARD Citation
Hughes, B. et al. (2014). Pertuzumab and Erlotinib in Patients With Relapsed Non‐Small Cell Lung Cancer: A Phase II Study Using 18F‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging. Oncologist. pp. 175-176. [Online].